Investors
Meyonex Pharmaceuticals presents a manufacturing-focused business profile built around organized plant infrastructure, oral solid dosage capability, quality-oriented systems, and export-oriented operations. This page is designed to give serious business visitors a concise overview of the company’s operating profile and manufacturing readiness.
Tarapur MIDC
Independent unit
Oral Solids
Manufacturing focus
6 Markets
Referenced export profile
QA / QC
Operating structure
Company Snapshot
Meyonex is presented as a pharmaceutical manufacturing company with an independent unit at Tarapur MIDC, an oral solid dosage focus, and a business profile oriented toward both domestic and international relationships.
Meyonex is positioned around business-facing pharmaceutical manufacturing rather than consumer-health or retail product messaging.
The operating base is an independent manufacturing unit located at Tarapur MIDC, Maharashtra.
The manufacturing profile is concentrated around tablets, capsules, and oral powder formats.
The company profile supports both domestic business relationships and export-oriented international positioning.
Plant capability, quality systems, documentation discipline, and production readiness form the basis of the business snapshot.
Manufacturing Profile
Meyonex’s manufacturing profile is deliberately focused on oral solid dosage capability, giving business evaluators a more specialized and credible operating story than a broad unsupported catalogue.
Tablet manufacturing is positioned as a core oral solid capability supported by organized production areas and equipment-backed operations.
Compression machines, coating systems, granulation equipment, and blending systems support the tablet profile.
Capsule manufacturing sits within the same oral solid setup and is framed for dependable B2B manufacturing relationships.
Capsule filling support and controlled process areas reinforce structured commercial manufacturing readiness.
Oral powder capability is part of the broader oral solid manufacturing setup without expanding beyond the confirmed dosage scope.
Dry powder and sachet filling support selected powder-based manufacturing requirements.
Installed Capacity Snapshot
Installed production strength helps connect Meyonex’s manufacturing story to business readiness, continuity of supply, and commercial-scale support.
Daily installed capacity
12 Million
Tablets / Day
4 Million
Capsules / Day
0.025 Million
Oral Powder Units / Day
Annual installed capacity
3744 Million
Tablets / Year
1200 Million
Capsules / Year
7.5 Million
Oral Powder Units / Year
Facility Snapshot
The facility profile is built around an independent manufacturing unit with organized floor-wise structure and distinct production, support, and utility-linked operating areas.
Quality Systems Snapshot
Quality support is framed through dedicated QA and QC structure, in-house QC infrastructure, documentation-oriented operations, and controlled design features that support more disciplined business evaluation.
International Business Profile
Meyonex presents itself as an export-oriented manufacturer serving domestic and international business relationships, with current referenced markets limited to the countries shown here.
Current referenced markets across Africa in the business profile materials.
Current referenced market in Asia in the business profile materials.
Current referenced market in Europe in the business profile materials.
Leadership Snapshot
Leadership is presented here as a concise operating structure rather than a full team directory, helping serious business visitors understand the management and functional oversight behind Meyonex’s manufacturing profile.
Managing Director
Provides company-level leadership across operations and overall business direction.
Director
Supports the business and management structure behind Meyonex’s operating profile.
Vice President, Operations
Provides operational oversight across the manufacturing environment and day-to-day execution structure.
Functional oversight
Quality Control · Production · Quality Assurance · Microbiology
Why This Matters
This page is structured as a concise business evaluation summary, connecting manufacturing, quality, facility, and market orientation in one place.
A defined oral solid dosage scope makes the operating profile easier to evaluate and more credible for business review.
Installed tablet, capsule, and oral powder capacity supports continuity-minded manufacturing discussions.
A dedicated facility with structured operational areas reinforces seriousness of execution and manufacturing readiness.
QA, QC, documentation, and controlled operating systems strengthen the due-diligence profile.
Domestic and international positioning gives business partners a clearer picture of Meyonex’s market-facing orientation.
Media / Business Profile Support
This section is designed to support approved plant, laboratory, and production visuals later while remaining polished for business review today.
Reserved slot for facility overview visuals.
Reserved slot for quality control and laboratory visuals.
Reserved slot for controlled production area visuals.
Reserved slot for commercial-scale manufacturing visuals.
Inquiry / Document Request
Meyonex combines focused dosage capability, organized plant infrastructure, production scale, and quality-oriented operating systems to support serious business evaluation for manufacturing partnerships and long-term commercial growth.
For detailed business discussions, contact our team directly.
